Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia

Clinical trial NCT03718234 · COMPLETED

Trial details

NCT number: NCT03718234
Sponsor: University of Minnesota
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Adrenal Hyperplasia Hyperplasia Adrenal Hyperplasia Congenital Disorders Adrenocortical Hyperfunction Disorders of Sex Development Urogenital Abnormalities Genetic Diseases, Inborn Steroid Metabolic Diseases, Inborn Adrenal Gland Disease Hydrocortisone

Start date: 2019-01-01
Primary completion: 2023-02-23
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.